Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease

Inflammation Research

Volumn 63, Issue 11, 2014, Pages 943-950

  Jiang, Wenyu ^a,b   Su, Jiewen ^a   Zhang, Xiaofei ^a   Cheng, Xiuqin ^a   Zhou, Jun ^a   Shi, Ruihua ^a   Zhang, Hongjie ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Crohn s disease (CD); IL 17; IL 21; IL 22; Inflammatory bowel disease (IBD); Th17 Cells; Ulcerative colitis (UC)

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE ENDOSCOPY; INTESTINE MUCOSA; MALE; PROTEIN BLOOD LEVEL; TH17 CELL; THROMBOCYTE; ULCERATIVE COLITIS; BLOOD; COLON; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKINS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; TH17 CELLS; YOUNG ADULT;

EID: 84920052435     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-014-0768-7     Document Type: Article

References (27)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.
2. Abraham Clara, Medzhitov Ruslan. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729–37.
3. Fuss IJ. Is the Th1/Th2 paradigm of immune regulation applicable to IBD? Inflamm Bowel Dis. 2008;14(Suppl. 2):S110–2.
4. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52:65–70.
5. Fantini MC, Monteleone G, MacDonald TT. IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol. 2008;1(2):110–5.
6. Andoh A, Zhang Z, Inatomi O, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005;129:969–84.
7. Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010. Inflamm Bowel Dis. 2010;16:112–24.
8. Daperno M, D’ Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for disease: the SES-CD. Gastrointest Endosc. 2004;60:505–12.
9. Tsai YS, Jou YC, Lee GF, Chen YC, Shiau AL, et al. Aberrant prothymosin-alpha expression in human bladder cancer. Urology. 2009;73:188–92.
10. Ryu JW, Lee JH, Choi YH, Lee YT, Choi BT. Effects of protein phosphatase inhibitors on the phosphorylation of spinal cord N-methyl-D-aspartate receptors following electroacupuncture stimulation in rats. Brain Res Bull. 2008;75:687–91.
11. Raza A, Yousaf W, Giannella R, et al. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol. 2012;8(2):161–8.
12. Niu Q, Cai B, Huang ZC, et al. Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol Int. 2011 Aug 2. [Epub ahead of print].
13. Becher B. Segal BM.T(H)17 cytokines in autoimmune neuro-inflammation. Curr Opin Immunol. 2011;23(6):707–12.
14. Eastaff-Leung N, Mabarrack N, Barbour A, et al. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010;30(1):80–9.
15. Holtta Veera, Klemetti Paula, Salo Harri M, et al. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;57(3):287–92.
16. Laan M, Lo¨tvall J, Chung KF, et al. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol. 2001;133:200–6.
17. Awane M, Andres PG, Li DJ, et al. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNFalpha-, and IL-1beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999;162:5337–44.
18. Kolls JK, Linden A. IL-17 family members and inflammation. Immunity. 2004;21:467–76.
19. Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology. 2009;126:177–85.
20. Bai A, Lu N, Guo Y, et al. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol. 2009;86(4):959–69.
21. Yamamoto-Furusho JK, Miranda-Pérez E, Fonseca-Camarillo G, et al. Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis. Inflamm Bowel Dis. 2010;16(7):1090.
22. Strengell M, Sareneva T, Foster D, et al. IL-21 up-regulates the expression of gene associated with innate immunity and Th1 response. J Immunol. 2002;169:3600–5.
23. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57–79.
24. Qi W, Huang X, Wang J. Correlation between Th17 cells and tumor microenvironment. Cell Immunol. 2013;285(1–2):18–22.
25. Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol. 2011;23(3):159–63.
26. Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:707–12.
27. Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child. 2004;89(1):69–71.